# American Strategic Investment Co.: financial statements, quarterly

NYC · NYSE · CIK 1595527 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nyc.md) · [Financials](/companies/nyc/financials.md) · [Filings](/companies/nyc/filings.md) · [Insiders](/companies/nyc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nyc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(4.7)](/filings/0001410578-24-001890.md) | [(69.1) d](/filings/0001628280-26-025292.md) | [(2.9)](/filings/0001628280-25-024226.md) | [(86.7)](/filings/0001628280-25-039258.md) | [(29.2)](/filings/0001595527-25-000014.md) | [(2.4) d](/filings/0001628280-26-025292.md) | [(4.5)](/filings/0001628280-26-035536.md) | [(33.8)](/filings/0001628280-26-056274.md) | [43.0](/filings/0001595527-25-000014.md) | [(0.3) d](/filings/0001628280-26-025292.md) | [(1.5)](/filings/0001628280-26-035536.md) | [(1.9)](/filings/0001628280-26-056274.md) |
| Interest expense | $m | [4.7](/filings/0001595527-23-000034.md) | [4.7 d](/filings/0001595527-24-000006.md) | [4.7](/filings/0001595527-24-000011.md) | [5.2](/filings/0001595527-24-000017.md) | [5.3](/filings/0001595527-25-000014.md) | [4.3 d](/filings/0001628280-26-025292.md) | [4.1](/filings/0001628280-26-035536.md) | [7.9](/filings/0001628280-26-056274.md) | [4.1](/filings/0001595527-25-000014.md) | [4.1 d](/filings/0001628280-26-025292.md) | [4.0](/filings/0001628280-26-035536.md) | [4.1](/filings/0001628280-26-056274.md) |
| Income tax | $m | [0.0](/filings/0001595527-23-000034.md) | [0.0 d](/filings/0001628280-26-025292.md) | [0.0](/filings/0001595527-24-000011.md) | [0.0 d](/filings/0001595527-24-000017.md) | [0.0 d](/filings/0001410578-24-001890.md) | [0.0 d](/filings/0001628280-26-025292.md) | [0.0](/filings/0001628280-26-035536.md) | [0.0](/filings/0001628280-26-056274.md) | [0.0 d](/filings/0001595527-25-000014.md) | [0.0 d](/filings/0001628280-26-025292.md) | [0.0](/filings/0001628280-26-035536.md) | [0.0](/filings/0001628280-26-056274.md) |
| Net income | $m | [(9.4)](/filings/0001410578-24-001890.md) | [(73.9) d](/filings/0001628280-26-025292.md) | [(7.6)](/filings/0001628280-25-024226.md) | [(91.9)](/filings/0001628280-25-039258.md) | [(34.5)](/filings/0001595527-25-000014.md) | [(6.7) d](/filings/0001628280-26-025292.md) | [(8.6)](/filings/0001628280-26-035536.md) | [(41.7)](/filings/0001628280-25-039258.md) | [35.8](/filings/0001595527-25-000014.md) | [(6.7) d](/filings/0001628280-26-025292.md) | [(7.8)](/filings/0001628280-26-035536.md) | [(8.3)](/filings/0001628280-26-056274.md) |
| Diluted EPS | $ per share | [(4.10)](/filings/0001410578-24-001890.md) | not reported | [(3.28)](/filings/0001628280-25-024226.md) | [(36.48)](/filings/0001628280-25-039258.md) | [(13.52)](/filings/0001595527-25-000014.md) | not reported | [(3.39)](/filings/0001628280-26-035536.md) | [(16.39)](/filings/0001628280-26-056274.md) | [13.60](/filings/0001595527-25-000014.md) | not reported | [(3.04)](/filings/0001628280-26-035536.md) | [(3.04)](/filings/0001628280-26-056274.md) |
| Basic EPS | $ per share | [(4.10)](/filings/0001410578-24-001890.md) | not reported | [(3.28)](/filings/0001628280-25-024226.md) | [(36.48)](/filings/0001628280-25-039258.md) | [(13.52)](/filings/0001595527-25-000014.md) | not reported | [(3.39)](/filings/0001628280-26-035536.md) | [(16.39)](/filings/0001628280-26-056274.md) | [13.60](/filings/0001595527-25-000014.md) | not reported | [(3.04)](/filings/0001628280-26-035536.md) | [(3.04)](/filings/0001628280-26-056274.md) |

- Revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss, us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.1](/filings/0001410578-24-001890.md) | [5.3](/filings/0001628280-26-025292.md) | [5.3](/filings/0001628280-25-024226.md) | [5.2](/filings/0001628280-25-039258.md) | [5.2](/filings/0001595527-25-000014.md) | [9.8](/filings/0001628280-26-025292.md) | [7.1](/filings/0001628280-26-035536.md) | [5.3](/filings/0001628280-26-056274.md) | [3.4](/filings/0001595527-25-000014.md) | [1.3](/filings/0001628280-26-056274.md) | [2.5](/filings/0001628280-26-035536.md) | [2.4](/filings/0001628280-26-056274.md) |
| Total assets | $m | [770](/filings/0001595527-23-000034.md) | [694](/filings/0001628280-25-013880.md) | [690](/filings/0001595527-24-000011.md) | [599](/filings/0001595527-24-000017.md) | [568](/filings/0001410578-24-001890.md) | [507](/filings/0001628280-26-025292.md) | [499](/filings/0001628280-25-024226.md) | [464](/filings/0001628280-25-039258.md) | [448](/filings/0001595527-25-000014.md) | [445](/filings/0001628280-26-056274.md) | [445](/filings/0001628280-26-035536.md) | [445](/filings/0001628280-26-056274.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [99.0](/filings/0001628280-25-039258.md) | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [471](/filings/0001595527-23-000034.md) | [469](/filings/0001628280-25-013880.md) | [472](/filings/0001595527-24-000011.md) | [472](/filings/0001595527-24-000017.md) | [476](/filings/0001410578-24-001890.md) | [421](/filings/0001628280-26-025292.md) | [422](/filings/0001628280-25-024226.md) | [428](/filings/0001628280-25-039258.md) | [377](/filings/0001595527-25-000014.md) | [380](/filings/0001628280-26-056274.md) | [388](/filings/0001628280-26-035536.md) | [392](/filings/0001628280-26-056274.md) |
| Shareholders' equity | $m | [299](/filings/0001595527-23-000034.md) | [225](/filings/0001628280-25-013880.md) | [217](/filings/0001595527-24-000011.md) | [127](/filings/0001595527-24-000017.md) | [92.4](/filings/0001410578-24-001890.md) | [85.6](/filings/0001628280-26-025292.md) | [77.1](/filings/0001628280-25-024226.md) | [35.5](/filings/0001628280-25-039258.md) | [71.4](/filings/0001595527-25-000014.md) | [64.8](/filings/0001628280-26-056274.md) | [57.1](/filings/0001628280-26-035536.md) | [52.9](/filings/0001628280-26-056274.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [245 d](/filings/0001410578-24-001890.md) | [(3,473) d](/filings/0001628280-26-025292.md) | [1,655](/filings/0001628280-25-024226.md) | [(916) d](/filings/0001628280-25-039258.md) | [2,565 d](/filings/0001595527-25-000014.md) | [(7,303) d](/filings/0001628280-26-025292.md) | [(3,037)](/filings/0001628280-26-035536.md) | [(2,502) d](/filings/0001628280-26-056274.md) | [777 d](/filings/0001595527-25-000014.md) | [(2,991) d](/filings/0001628280-26-025292.md) | [(182)](/filings/0001628280-26-035536.md) | [352 d](/filings/0001628280-26-056274.md) |
| Dividends paid | $k | [0.0 d](/filings/0001595527-23-000034.md) | [0.0 d](/filings/0001628280-25-013880.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,845](/filings/0001595527-23-000013.md) | [2,039](/filings/0001595527-24-000011.md) | [2,287](/filings/0001595527-24-000017.md) | [2,289](/filings/0001410578-24-001890.md) | [2,323](/filings/0001628280-25-024226.md) | [2,518](/filings/0001628280-25-039258.md) | [2,551](/filings/0001595527-25-000014.md) | [2,534](/filings/0001628280-26-035536.md) | [2,541](/filings/0001628280-26-056274.md) | [2,630](/filings/0001595527-25-000014.md) | [2,557](/filings/0001628280-26-035536.md) | [2,734](/filings/0001628280-26-056274.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,163,632 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001628280-26-056274.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.